ODDB.org: Open Drug Database | Médicaments | Information professionnelle

Home - Ipro sur Androderm

Information professionnelle sur Androderm:

AstraZeneca AG

Information professionnelle complète	DDD	imprimé
Forme gal./Grpe.th.	Composit.	Propriétés	Pharm.cinét.	Indic./emploi	Posolog./mode d'empl.	Précautions	Effets indésir.
Interact.	Surdosage	Remarques	Num. Swissmedic	Mise à jour

G03BA03 - Testosterone

ATC-DDD Version 2016. Source: WHO

G - Genito Urinary System and Sex Hormones

G03 - Sex Hormones and Modulators Of The Genital System

Other hormones, see H - Systemic hormonal preparations, excl. sex hormones and insulins.
Sex hormones used only in the treatment of neoplastic diseases (often selected strengths) are classified in L - Antineoplastic and immunomodulating agents.

The DDDs of many of the hormone preparations may vary considerably with the route of administration due to substantial differences in bioavailability. The DDDs of depot preparations are calculated as the dose divided by the dosing interval.

G03B - Androgens

Anabolic steroids, see A14A. Norethandrolone, which has both anabolic and androgenic effects, is classified in A14A since the anabolic effect is considered to be the most important effect.
This group comprises male sex hormones. Combined preparations are included in this group, except combinations with female sex hormones, which are classified in G03E - Androgens and female sex hormones in combination.
The group is subdivided according to chemical structure.

G03BA - 3-Oxoandrosten (4) Derivatives

The DDD for parenteral and oral testosterone is expressed as declared amount of ester. The DDD for TD and SL route of administration is expressed as declared amount of testosterone.

G03BA03 - Testosterone

Concentr.	Adm.Route	Note
	S
	TD	gel
	R
	P
	TD
	O

2025	©ywesee GmbH